Helicobacter pylori, an important human pathogen, is capable of causing persistent infection with minimal immune response. The first line of defense during H. pylori infection is through gastric epithelial cells that present TLR. A family of bacterial proteins that share homology with the Toll/IL-1 receptor (TIR) domain were identified. Bacterial TIR proteins (BTP) mimic human TIR domain proteins and act on myeloid differentiation primary response gene 88 (MyD88) signaling pathways to suppress TLR signaling. H. pylori may also produce a similar protein. A putative H. pylori BTP was found based on sequence homology. The corresponding gene hp1437 was inserted into an expression vector in fusion with an N-terminal cleavable 6his-tag. The recombinant protein, 6his-HP1437, was purified using nickel affinity chromatography with a yield of 8 mg/L culture. Oligomerization of HP1437 was investigated by size-exclusion chromatography. It was found that HP1437 forms dimers in solution similar to other BTPs. Furthermore, glutathione S-transferase pull down assays identified an interaction between HP1437 and human TIR domain adaptor MyD88. These findings suggest that HP1437 has the characteristic features of BTPs and may play a direct role in reducing immune response against H. pylori by binding to MyD88 and pave the way for an in-depth characterization of this putative novel H. pylori virulence factor.
domains in close proximity and thus favoring their dimerization and recruitment of cytoplasmic adaptor molecules. The molecular mechanism behind intracellular signal transduction is interactions between conserved structural units that are found in cytoplasmic domains of receptors and adaptor proteins. These structural units are designated as TIR domains and are composed of a five stranded parallel b-sheet surrounded by a-helices (5) .
Dimerization of receptor TIR domains creates a platform to which adaptor TIR domains can bind. The central adaptor in TLR signaling is MyD88. TRIF is another adaptor that can bind to TLR4, creating an alternative to the MyD88 pathway. MyD88-adaptor-like (also known as TIRAP), TRIF-related adaptor molecule and sterile a-and armadillo-motif-containing protein are the other known human TIR domain adaptors (6) .
Recently, a class of bacterial proteins that share homology with the TIR domain has been identified. Those from Brucella (BtpA and BtpB), uropathogenic Escherichia coli (TcpC), Salmonella (TlpA) and Yersinia (YpTIR) have been characterized and their effects on TLR signaling documented (7) (8) (9) (10) (11) . BtpA has been shown to be directly involved in the virulence of Brucella (11) and the crystal structure of BtpA confirms the presence of a TIR domain fold (12) . The BtpA TIR domain has been shown to be similar to human TIR domain adaptor proteins MyD88 and TIRAP (12) . It has been found that this structural mimicry enables BtpA to interact with MyD88 and TIRAP and interfere with TLR signaling (13) .
It is yet to be determined whether other bacterial proteins with putative TIR domains also function in bacterial pathogenesis. In this study, we therefore investigated the possibility that H. pylori has a TIR domain containing virulence factor analogous to BtpA that can play a role in suppressing TLR signaling. Our bioinformatic searches using the known TIR domain protein sequences resulted in one putative H. pylori TIR domain (HP1437) sequence. To investigate HP1437's TIR domain properties, we expressed and purified the recombinant protein and found that the purified protein exists as a dimer in solution and interacts with the human adaptor protein MyD88. Exploration of the structural features of HP1437 by homology modeling determined that it is a two-domain protein with a C-terminal TIR domain.
MATERIALS AND METHODS

Cloning, expression, and purification of HP1437
A 720 bp PCR fragment encoding HP1437 from H. pylori strain 26695 was cloned into the pET151D topo vector (Invitrogen, Carlsbad, CA, USA) (forward primer: 5 0 -ACCATGAGTGAAAACATTAAAGGAAAATATATC -3 0 , reverse primer: 5 0 -CTACAAATTGATTTGTTGT-GATAGC-3 0 ). E. coli BL21(DE3) pLysS cells carrying the construct were grown in LB medium with ampicillin at 37°C until OD 600 of 0.6 was achieved, after which protein expression was induced by addition of 1 mM IPTG. Induction was continued for 3 hr at 37°C and then the cells were harvested by centrifugation. The pellets were resuspended in lysis buffer (50 mM Tris pH 8, 250 mM NaCl, 10% [v/v] glycerol, 1% [v/v] Triton X-100) supplemented with 10 mg/mL DNase-I, 10 mM MgCl 2 , 1 mg/mL lysozyme and protease inhibitor tablets (Pierce, Rockford, IL, USA). The cells were disrupted using glass beads and the lysate cleared by centrifugation (16,000 g for 20 min). The supernatant, mixed with 1 mL HisPur Ni-NTA resin (Pierce) pre-equilibrated with buffer A (50 mM Tris pH 8, 150 mM NaCl, 5% [v/v] glycerol), was incubated on ice for 1 hr and loaded to a 10 mL plastic column. Successive washes were carried out with buffer A, 10% (v/v) buffer B (buffer A with 250 mM imidazole) and 1 M NaCl. The protein was eluted with a step gradient from 10 to 100% of buffer B. Fractions containing 6his-HP1437 were pooled and dialyzed against buffer A to remove the imidazole. Protein used for size exclusion chromatography was incubated with TEV protease (1:40), 1 mM DTT and 0.5 mM EDTA, dialyzed against buffer A overnight and then loaded on a HisPur Ni-NTA column. Pure HP1437 was eluted with buffer A. After each step of purification, fractions were analyzed on 12% SDS-PAGE (14) .
Size-exclusion chromatography 1 mg/mL HP1437 were applied to a size exclusion chromatography column (Superdex 75 10/300 GL; GE Healthcare, Piscataway, NJ, USA) in buffer A with a flowrate of 0.6 mL/min. The column was calibrated with a low molecular weight calibration kit (GE Healthcare) for molecular weight determination.
Expression and purification of MyD88
MyD88 was produced as a GST fusion from plasmid pETM30-MyD88. E. coli BL21(DE3) cells were transformed with pETM30-MyD88 and grown in LB medium with kanamycin at 37°C until an OD 600 of 0.6 was reached. Protein expression was induced by addition of 1 mM IPTG for 3 hr at 37°C and the cells harvested by centrifugation. Harvested cells were resuspended in lysis buffer (50 mM Tris pH 8, 300 mM NaCl, 5% [v/v] glycerol, 1 mM EDTA) supplemented with 5 mM DTT, 10 mg/mL DNase-I, 10 mM MgCl 2 , 1mg/mL lysozyme and protease inhibitor tablets (Pierce). The cells were disrupted using glass beads and the cell lysate cleared by centrifugation (16,000 g for 20 min). The cleared lysate was then mixed with 2 mL glutathione agarose resin (Pierce) preequilibrated with buffer C (50 mM Tris pH 8, 150 mM NaCl, 5% [v/v] glycerol, 1 mM EDTA and 5 mM DTT) and incubated in ice for 1 hr. The resin slurry was loaded onto a 10 mL plastic column and the column washed three times with buffer C. GST-MyD88 protein was left bound on glutathione resin for GST pull down assay. GST was expressed and purified by a similar method for GST pull down negative control experiments.
GST pull down assay 1 mg/mL 6his-1437 was diluted in buffer C, after which 160 mg of 6his-1437 was added to 2 mL MyD88-bound glutathione resin and incubated at 4°C for 1 hr. The resin was washed with 2 mL buffer C four times and total protein content eluted by boiling the resin in 50 mL SDS-PAGE sample buffer at 95°C for 10 min. Samples were analyzed by Coomassie brilliant blue R250 staining. In control experiments, 2 mL of glutathione resin alone or GST-bound glutathione resin were subjected to the same procedure.
RESULTS
Identification of H. pylori TIR domain protein using bioinformatic analysis HP1437 (NP_208228.1), a 239 amino acid protein, has a predicted C-terminal TIR domain similar to other bacterial TIR domain proteins (8, 11, 15) . A multiple sequence alignment with bacterial and human TIR domains ( Fig. 1) showed conservation of TIR domain signature regions box I and box II (16) . Both full length Fig. 1 . Multiple sequence alignment of HP1437 with bacterial (BtpA, TcpC, TlpA, PdTIR) and human adaptor (MyD88, TIRAP) TIR domain proteins. The alignment was done using PSI-Coffee (21) and formatted using ESPript (22) with secondary structure information from BtpA (pdb: 4lzpB). The predicted start of TIR domain of HP1437 is marked with a star.
and TIR domains of HP1437 are most similar to Salmonella TlpA (24% and 26%, respectively) and the sequence similarity to BTPs is greater than to that of human TIR domain adaptors (Tables 1, 2 ). Although there is little overall sequence similarity, the amino acids in the secondary structure regions, especially those in beta strands, are well conserved in HP1437 (Fig. 1) .
To verify the presence of the TIR domain fold, several models were generated using different methods through Protein Model Portal (17) ; the best models were obtained using I-TASSER (18) and IntFOLD (19) . The top model generated by IntFOLD Server indicated a two-domain protein, with the TIR domain starting from K82, in agreement with the multiple alignment findings (Fig. 1 ). Separate models were generated for the N-termini and C-termini. The N-termini of the protein were modeled as long extended tails (data not shown). The structural models for C terminus region of HP1437 (amino acids K82-L239) adopted a TIR domain fold with a four-stranded parallel beta-sheet, surrounded by five helices and loops (Fig. 2) . The last beta sheet was modeled as a loop, because it is very short (Fig. 2a) . Although core fold is conserved between HP1437 and Brucella BtpA, there are variations between the two structures in the loop and helical regions (Fig. 2c,e) .
Expression and purification of HP1437
To produce and purify the H. pylori TIR domain protein, hp1437 gene (from strain 26695) was amplified by PCR and cloned in fusion with a cleavable N-terminal his tag. Initially E. coli BL21(DE3) and BL21(DE3) star cells were transformed with 6his-HP1437 encoding plasmids; however, no colonies were obtained, possibly because HP1437 protein is toxic to E. coli cells. To prevent leaky protein expression, E. coli BL21(DE3) pLysS cells were used for recombinant protein production. The recombinant protein was purified by nickel affinity purification with a yield of 8 mg 6his-1437/L culture.
Oligomeric state of HP1437
The oligomeric state of HP1437 in solution was determined using size exclusion chromatography. The his-tag was removed by TEV protease cleavage and analysis of HP1437 on a Superdex 75 column yielded an apparent molecular weight of 54 kDa based on elution volume and a calibration curve (Fig. 3) . In contrast, the expected molecular weight of HP1437 based on its amino acid sequence was 28 kDa. Size exclusion chromatography thus showed that the protein is dimeric in solution. Identity of HP1437 to others are shown in bold. Identity of HP1437 to others are shown in bold.
Interaction of HP1437 with MyD88
A possible interaction between HP1437 and human MyD88 was investigated using an in vitro GST pull down assay. HP1437 was applied to GST-MyD88 bound resin, which was then washed and the remaining proteins bound to the resin analyzed by SDS-PAGE (Fig. 4a) . Figure 4 shows that MyD88 and HP1437 interact, as evidenced by HP1437 co-eluting with GST-MyD88 after washing. HP1437 did not bind to GST alone (Fig. 4b) ; it was found in flow through and wash fractions when applied to GST-bound resin without MyD88.
DISCUSSION
In this study, a sequence-based search identified HP1437, which contains the signature sequence regions found in TIR domain proteins, as a putative TIR domain protein. Homology modeling of HP1437 showed that the protein contains two structural domains, the N-terminus displaying a loose helical conformation. Brucella TIR domain protein (BtpA) is also composed of two domains in which the N-terminus has an extended helical tail like structure (12) . Thus, there is also structural similarity between the non-TIR domain regions of HP1437 and BtpA. Furthermore, it appears that flexible N-terminal domain may be a signature for pathogenic TIR domain proteins. According to our model, the C terminus of HP1437 adopts a TIR domain fold. The core of the structure, the central parallel beta sheets, is similar to that of BtpA, whereas the helical and loop regions are different. TIR domains act as important signaling regulators; several studies have shown that interaction interfaces are formed by helical and loop regions. The differences in loop regions have been shown to be important for the selectivity of protein interactions of TLR and adaptor TIR domains. Several loops, including BB and DD loops, have been shown to be important for mediating heterotypic interactions (25, 26) . Thus, variations in these parts of the structures may be necessary and important for signaling specificity and selectivity.
HP1437 formed dimers in solution and interacted with MyD88 in GST pull down assays. TIR domains function by interaction with themselves and other TIR domains. Other bacterial TIR domain proteins have also been shown to be dimeric in solution (7, 12) .
The in vitro interaction between MyD88 and HP1437 TIR domains may indicate that HP1437 can hijack MyD88 by preventing its interaction with the receptor. This has been shown for Brucella BtpA TIR domain, which can inhibit TLR signaling pathways by interacting with MyD88 and TIRAP (9, 11, 13) . The present study identifies HP1437 as a candidate protein for future investigation of the effects of H. pylori on TLR signaling and contributes to our understanding of the altered immune responses and persistent infection associated with this human pathogen. It is yet to be determined whether the MyD88-HP1437 interaction occurs in vivo and affects TLR signaling pathways. Furthermore, it should be investigated if and how HP1437 is internalized into host cells. BtpA has been shown to be translocated into host cells via the T4SS of Brucella (11). H. pylori also possess a T4SS that is used for translocation of the oncoprotein CagA (27, 28) . Thus far, CagA is the only protein effector known to be translocated by T4SS. It is however interesting to note that other virulence factors such as VacA, NAP, CtkA and Tip-a are translocated independently of T4SS (29) (30) (31) . HP1437 apparently has no signal peptide, like CtkA. CtkA protein has been shown to be directly translocated to human cells (30) ; this may also be the case for HP1437. Similarly, Brucella BtpA has also been shown to be a cell permeable protein (32) . Likewise Salmonella TlpA, E. coli TcpC and E. faecalis TcpF have been shown to be directly internalized by macrophages (9, 10, 33) . These proteins also do not contain secretion signal sequences, yet TcpC has been shown to be secreted into the media of cultured bacterial cells (9) .
Several BTPs have been shown to be necessary for virulence of a pathogen. E. coli TcpC and Salmonella TlpA deletion mutants have been shown to be defective regarding both intracellular survival and pathogenesis (9, 10) . Brucella BtpA mutant reportedly grows slower in mouse models and infected animals survive longer when infected with BtpA deficient Brucella (34). Similarly BtpB has been shown to play a direct role in virulence and infection (11) . HP1437 is encoded by several H. pylori genomes, including CagA positive strains. Based on these observations, it is possible that H. pylori needs HP1437 for survival in the host. Further research should focus on survival and virulence of HP1437 deletion mutants. 
